Clinical data showed that highly-expressed NEAT1 is closely correlated with a shorter survival rate, a poor differentiation degree, larger tumors, an advanced FIGO stage, and significant peritoneal metastasis in patients with ovarian cancer [10]. Here, NEAT1 is linked to ovarian carcinoma.